WRM
ALXN

Westport Resources Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Westport Resources Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-850
Closed -$8K – 868
2015
Q4 		$8K Sell
850
-50
-6% -$8.73K ﹤0.01% 745
2015
Q3 		$9K Sell
900
-60
-6% -$10.9K ﹤0.01% 750
2015
Q2 		$10K Sell
960
-150
-14% -$25.9K ﹤0.01% 752
2015
Q1 		$11K Sell
1,110
-40
-3% -$7.24K ﹤0.01% 791
2014
Q4 		$12K Hold
1,150
– – ﹤0.01% 815
2014
Q3 		$12K Hold
1,150
– – ﹤0.01% 814
2014
Q2 		$12K Hold
1,150
– – ﹤0.01% 844
2014
Q1 		$175K Hold
1,150
– – 0.05% 317
2013
Q4 		$153K Sell
1,150
-100
-8% -$12K 0.04% 328
2013
Q3 		$145K Buy
1,250
+200
+19% +$21.9K 0.05% 310
2013
Q2 		$97K Buy
+1,050
New +$101K 0.03% 365

Other funds holding ALXN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return

Westport Resources Management's ALXN Position: Q1 2016 in Review

Westport Resources Management sold out of Alexion Pharmaceuticals (ALXN) in Q1 2016, closing a stake of 850 shares — an estimated $8K sold.

Westport Resources Management first reported a position in ALXN in Q2 2013 and held it in 11 quarters. The position peaked at $175K in Q1 2014. 520 funds tracked by Wall St. Rank hold ALXN as of Q1 2016.

  • Westport Resources Management reported no remaining Alexion Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Westport Resources Management sold 850 Alexion Pharmaceuticals shares in Q1 2016, an estimated $8K.
  • Westport Resources Management first reported a position in Alexion Pharmaceuticals in Q2 2013 and held it in 11 quarters.
  • Westport Resources Management's Alexion Pharmaceuticals position peaked at $175K in Q1 2014.
  • 520 funds tracked by Wall St. Rank held Alexion Pharmaceuticals as of Q1 2016.

Based on Westport Resources Management's 13F filing for Q1 2016, filed 16 May 2016.